# Wenhua Liang

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/wenhua-liang/

## Facts

| Field | Value |
| --- | --- |
| Citations | 60,915 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 61 |
| i10-index | 244 |
| Last Known Institution | First Affiliated Hospital of Guangzhou Medical University |
| OpenAlex ID | https://openalex.org/A5031255136 |
| ORCID iD | https://orcid.org/0000-0002-1391-8238 |
| Works | 528 |

## Researcher papers

- [Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China](https://scholariq.org/papers/cancer-patients-in-sars-cov-2-infection-a-nationwide-analysis-in-china/)
- [Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis](https://scholariq.org/papers/comorbidity-and-its-impact-on-1590-patients-with-covid-19-in-china-a-nationwide/)
- [Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19](https://scholariq.org/papers/development-and-validation-of-a-clinical-risk-score-to-predict-the-occurrence-of/)
- [Clinically Applicable AI System for Accurate Diagnosis, Quantitative Measurements, and Prognosis of COVID-19 Pneumonia Using Computed Tomography](https://scholariq.org/papers/clinically-applicable-ai-system-for-accurate-diagnosis-quantitative-measurements/)
- [Comorbidity and its impact on 1,590 patients with COVID-19 in China: A Nationwide Analysis](https://scholariq.org/papers/comorbidity-and-its-impact-on-1-590-patients-with-covid-19-in-china-a-nationwide/)
- [EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy](https://scholariq.org/papers/ebv-driven-lmp1-and-ifn-up-regulate-pd-l1-in-nasopharyngeal-carcinoma/)
- [Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non–Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional Registry](https://scholariq.org/papers/impact-of-examined-lymph-node-count-on-precise-staging-and-long-term-survival-of/)
- [Clinical characteristics and outcomes of hospitalised patients with COVID-19 treated in Hubei (epicentre) and outside Hubei (non-epicentre): a nationwide analysis of China](https://scholariq.org/papers/clinical-characteristics-and-outcomes-of-hospitalised-patients-with-covid-19/)
- [Early triage of critically ill COVID-19 patients using deep learning](https://scholariq.org/papers/early-triage-of-critically-ill-covid-19-patients-using-deep-learning/)
- [Ivonescimab Plus Chemotherapy in Non–Small Cell Lung Cancer With <i>EGFR</i> Variant](https://scholariq.org/papers/ivonescimab-plus-chemotherapy-in-non-small-cell-lung-cancer-with-i-egfr-i/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)

## Researcher university

- [First Affiliated Hospital of Guangzhou Medical University](https://scholariq.org/institutions/first-affiliated-hospital-of-guangzhou-medical-university/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.